Sprung, Victoria S ORCID: 0000-0002-2666-4986, Kemp, Graham J
ORCID: 0000-0002-8324-9666, Wilding, John Ph
ORCID: 0000-0003-2839-8404, Adams, Valerie, Murphy, Kieran, Burgess, Malcolm, Emegbo, Stephen, Thomas, Matthew, Needham, Alexander J, Weimken, Andrew et al (show 4 more authors)
(2020)
Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apnea-hypnoea index (AHI).
BMJ OPEN, 10 (7).
Item Type: | Article |
---|---|
Uncontrolled Keywords: | sleep medicine, diabetes & endocrinology, protocols & guidelines |
Depositing User: | Symplectic Admin |
Date Deposited: | 10 Aug 2020 07:38 |
Last Modified: | 25 Jun 2022 07:10 |
DOI: | 10.1136/bmjopen-2020-038856 |
Open Access URL: | https://bmjopen.bmj.com/content/10/7/e038856 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3096949 |